Gene · 3635
Papers3,499
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,499
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of ribosomal protein family as immune-cell-related biomarkers of NAFLD by bioinformatics and experimental analyses. | Front Endocrinol (Lausanne) | 2023 | 37274336 | PubTator, text mining | PubMed |
| Non-oncology drug (meticrane) shows anti-cancer ability in synergy with epigenetic inhibitors and appears to be involved passively in targeting cancer cells. | Front Oncol | 2023 | 37274234 | PubTator, text mining | PubMed |
| Six mitophagy-related hub genes as peripheral blood biomarkers of Alzheimer's disease and their immune cell infiltration correlation. | Front Neurosci | 2023 | 37274215 | PubTator, text mining | PubMed |
| Inborn errors of human B cell development, differentiation, and function. | J Exp Med | 2023 | 37273190 | PubTator, text mining | PubMed |
| Alzheimer's disease pathogenetic progression is associated with changes in regulated retained introns and editing of circular RNAs. | Front Mol Neurosci | 2023 | 37266374 | PubTator, text mining | PubMed |
| SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy. | Front Immunol | 2023 | 37251372 | PubTator, text mining | PubMed |
| Expression and clinical significance of DOK3 in renal clear cell carcinoma. | J Int Med Res | 2023 | 37235715 | PubTator, text mining | PubMed |
| Dual inhibition of phosphoinositide 3-kinases delta and gamma reduces chronic B cell activation and autoantibody production in a mouse model of lupus. | Front Immunol | 2023 | 37234154 | PubTator, text mining | PubMed |
| Systemic lupus erythematosus: latest insight into etiopathogenesis. | Rheumatol Int | 2023 | 37226016 | PubTator, text mining | PubMed |
| Mechanistic/mammalian target of rapamycin complex 1 (mTORC1) signaling is involved in phagocytosis activation during THP-1 cell differentiation. | J Vet Med Sci | 2023 | 37225457 | PubTator, text mining | PubMed |
| Exosome Derived from Human Umbilical Cord Mesenchymal Cell Exerts Immunomodulatory Effects on B Cells from SLE Patients. | J Immunol Res | 2023 | 37215068 | PubTator, text mining | PubMed |
| Targeted hyperactivation of AKT through inhibition of ectopic expressed SHIP1 induces cell death in colon carcinoma cells and derived metastases. | Cell Signal | 2023 | 37207939 | PubTator, text mining | PubMed |
| Molecular regulatory mechanism of LILRB4 in the immune response. | Cent Eur J Immunol | 2023 | 37206591 | PubTator, text mining | PubMed |
| Transforming growth factor-β signaling: from tumor microenvironment to anticancer therapy. | Explor Target Antitumor Ther | 2023 | 37205317 | PubTator, text mining | PubMed |
| Multi-ancestry meta-analysis and fine-mapping in Alzheimer's disease. | Mol Psychiatry | 2023 | 37198259 | PubTator, text mining | PubMed |
| Role and mechanistic actions of protein kinase inhibitors as an effective drug target for cancer and COVID. | Arch Microbiol | 2023 | 37193831 | PubTator, text mining | PubMed |
| Epigenetics Approaches toward Precision Medicine for Idiopathic Pulmonary Fibrosis: Focus on DNA Methylation. | Biomedicines | 2023 | 37189665 | PubTator, text mining | PubMed |
| CLEC16A-An Emerging Master Regulator of Autoimmunity and Neurodegeneration. | Int J Mol Sci | 2023 | 37175930 | PubTator, text mining | PubMed |
| Uremic Toxin Indoxyl Sulfate Promotes Macrophage-Associated Low-Grade Inflammation and Epithelial Cell Senescence. | Int J Mol Sci | 2023 | 37175735 | PubTator, text mining | PubMed |
| Network analysis reveals a major role for 14q32 cluster miRNAs in determining transcriptional differences between IGHV-mutated and unmutated CLL. | Leukemia | 2023 | 37169950 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3635/papers?page=15